Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) EBT (2016 - 2025)

Haemonetics (HAE) has 17 years of EBT data on record, last reported at $60.0 million in Q4 2025.

  • For Q4 2025, EBT rose 20.15% year-over-year to $60.0 million; the TTM value through Dec 2025 reached $227.2 million, up 37.89%, while the annual FY2025 figure was $212.1 million, 39.64% up from the prior year.
  • EBT reached $60.0 million in Q4 2025 per HAE's latest filing, up from $51.3 million in the prior quarter.
  • Across five years, EBT topped out at $70.7 million in Q1 2025 and bottomed at -$27.4 million in Q2 2021.
  • Average EBT over 5 years is $34.9 million, with a median of $41.6 million recorded in 2022.
  • Peak YoY movement for EBT: tumbled 224.76% in 2021, then soared 947.54% in 2022.
  • A 5-year view of EBT shows it stood at $19.9 million in 2021, then skyrocketed by 111.95% to $42.2 million in 2022, then grew by 4.27% to $44.0 million in 2023, then grew by 13.37% to $49.9 million in 2024, then rose by 20.15% to $60.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $60.0 million in Q4 2025, $51.3 million in Q3 2025, and $45.2 million in Q2 2025.